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Elsevier Taiwan LLC. Open access under CSummary Background: Colonoscopy is a standard and useful examination in the diagnosis of
colorectal diseases; however, it usually causes pain to patients. Some patients receive narcotic
drugs, e.g., meperidine, for pain relief if a colonoscopy is carried out without sedation.
Whether the administration of such analgesic drugs to patients without sedation facilitates
the performance of the colonoscopy or reduces pain remains to be elucidated. The aim of this
study was to evaluate the analgesic effect of meperidine as premedication for patients under-
going a colonoscopy without sedation.
Patients and Methods: A total of 217 patients (109 men, 108 women) undergoing a diagnostic
colonoscopy without sedation were analyzed prospectively. The procedures were carried out
by three experienced endoscopists in a medical center. The patients could opt to receive anal-
gesic drugs, with 25 mg of meperidine being given intramuscularly prior to the procedure if re-
quested by either the doctor or patient. The colonoscopic examination was performed by one
person using the short-axis method. Questionnaires to evaluate abdominal pain during or after
colonoscopy without sedation were collected and analyzed for patients who used meperidine
as premedication (Group A) and for those who did not receive meperidine (Group B). Abdom-
inal pain was evaluated using a visual analog scale from 0 to 10. The cecal intubation rate, to-
tal insertion time, and the patient’s willingness to receive another colonoscopy in the future if
needed were also analyzed.
Results: In both groups, the cecal intubation rate was more than 99% with no significant differ-
ence between groups. The mean  standard deviation insertion time was 7.14  5.45 minutes
in Group A and 6.24  4.24 minutes in Group B (p Z 0.309). The visual analog pain score wasastroenterology, Department of Internal Medicine, Chung Shan Medical University Hospital, Number
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10 M.-C. Tsai et al.3.54  3.13 in Group A and 2.46  2.75 in Group B (pZ 0.009). After adjusting for age and sex,
the pain score was 3.51  3.21 in Group A (p Z 0.055). Multivariate analysis showed that fe-
male sex and the individual endoscopist performing the colonoscopy were associated with
abdominal pain during the examination.
Conclusion: In our study, premedication with meperidine or no premedication was not associ-
ated with a reduction in abdominal pain during colonoscopy without sedation. The insertion
time and cecal intubation rate showed no difference between patients with or without addi-
tional analgesic drugs prior to the procedure. However, as self-selection bias could not be ru-
led out, further randomized, placebo-controlled trials are needed to confirm our findings.
Copyright ª 2014, The Gastroenterological Society of Taiwan and The Digestive Endoscopy So-
ciety of Taiwan. Published by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.Introduction
Colonoscopy is a standard and useful examination in the
diagnosis of colorectal diseases. It is generally indicated for
screening and surveillance for colonic neoplasia, the eval-
uation of abnormalities on a barium enema, and the diag-
nosis of unexplained gastrointestinal bleeding, chronic
diarrhea, or inflammatory bowel disease [1]. It is often
uncomfortable and painful for patients and these unpleas-
ant symptoms always make the procedure more difficult to
perform without sedation. In the USA, the sedation of pa-
tients undergoing a colonoscopy is standard and is carried
out routinely [2,3]. However, sedation is associated with
enormous costs and a low risk of serious adverse events [4].
To reduce sedation-related side-effects, some facilities in
the USA offer patients an option of colonoscopy without
sedation [5e8]. In Taiwan and many Asian countries,
sedation is not routinely available and several studies have
reported the relative success of colonoscopy without
sedation [9e12]. Most patients received different narcotic
drugs, e.g., meperidine, for the relief of pain during a co-
lonoscopy without sedation. Whether the administration of
analgesic or narcotic drugs to patients facilitates the per-
formance of a colonoscopy without sedation or reduces the
painful sensations needs to be elucidated. We report here
the results of an evaluation of the analgesic effects of
meperidine as a premedication for patients undergoing a
colonoscopy without sedation.
Methods
This prospective study was conducted from July 2009 to
September 2009 in the Chung Shan Medical University
Hospital (Taichung, Taiwan), a tertiary medical center.
Three hundred and twenty-four consecutive outpatients
who received a diagnostic colonoscopy without sedation
were studied. Patients with the following conditions were
excluded: age less than 18 years (nZ 1), inadequate bowel
preparation (n Z 25), obstructive lesions of the colon
(n Z 4), contraindication to antispasmodic drugs or
meperidine (n Z 0), or unwilling to be evaluated for
abdominal pain or to attend this study (n Z 77). A total of
217 outpatients (109 men, 108 women) were enrolled.
All patients followed a colon-cleaning method with
24-hour dietary restriction and the ingestion of either 90 mLof sodium phosphate (C.B. Fleet, Lynchburg, VA, USA) or 2 L
of polyethylene glycol electrolyte lavage solution. Hyoscine
butylbromide (20 mg intramuscularly) was used as an
antispasmodic drug. Prior to colonoscopy, 25 mg meperi-
dine was offered as an option for premedication pain relief
and its use was decided by either the doctor or by patient
demand. Group A includes patients who received meperi-
dine as premedication and Group B includes those who did
not received meperidine.
All the colonoscopic examinations were performed by
one of three experienced endoscopists (C.C.L., T.H.C., or
M.C.T.; each endoscopist had a minimum experience of
2000 colonoscopies) with one person and the short-axis
method. Colonoscopies were carried out using an Olympus
CF-260AZI colonoscope (Olympus Optical, Tokyo, Japan).
Carbon dioxide was routinely used as the insufflating gas.
The procedure was conducted without sedation and the
doctor could explain the real-time findings and perform
therapeutic procedures (including biopsy and poly-
pectomy) if needed. Successful cecal intubation was
defined as reaching the cecum and taking the pictures of
the appendiceal orifice and the ileocecal valve. The cecal
intubation time was recorded as the time interval from
the initial insertion into the anal channel to cecum
intubation.
A trained research assistant who was blinded to the
premedication status administered the questionnaire and
evaluated the abdominal discomfort of the patients during
the procedure. Abdominal pain was graded by an 11-point
visual analog scale (VAS) from 0 to 10 (0 Z no pain,
10Z worst imaginable pain). We evaluated abdominal pain
during and immediately after the procedure. The patients
were also contacted by telephone 24 hours after the colo-
noscopy and abdominal pain was again recorded by the VAS.
The questionnaire also included the acceptance of the
procedure and the willingness to repeat a colonoscopy
without sedation depending on the patient’s condition and
doctor’s advice.
Quantitative data were summarized and are presented
as mean  standard deviation values. Continuous variables
were compared using the Student t test for normal data and
the ManneWhitney U test for non-normal data. Categorical
variables were compared using Fisher’s exact test for
different patient groups. We used logistic regression ana-
lyses to evaluate the importance of various factors to se-
vere abdominal pain (VAS 4) during colonoscopy and these
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interval (CI); p < 0.05 indicates statistical significance. All
analyses were performed with SPSS version 17.0 for Win-
dows (SPSS Inc., Chicago, IL, USA).
Results
A total of 217 patients underwent a diagnostic colonoscopy
without sedation from July 2009 to September 2009. Group
A included 77 patients (31 men and 46 women, mean age
51.6 years) who received 50 mg meperidine intramuscularly
prior to the colonoscopy. Group B included 140 patients (78
men and 62 women, mean age 50.7 years) who received no
analgesic drug (Table 1). The total cecal intubation rate
was more than 99% in both groups without a statistically
significant difference. The insertion time was 7.14  5.45
minutes in Group A and 6.24  4.24 minutes in Group B
(p Z 0.309). There was no difference in withdrawal time
between the two groups (Table 1). No major adverse event,
such as hypotension or respiratory distress, occurred in this
study.
Abdominal pain was evaluated using VAS (0e10). The
pain score during the procedure was 3.54  3.13 in Group A
and 2.46  2.75 in Group B (p Z 0.009). Group A patients
also had a higher pain score minutes after the procedure.
There was no difference in pain score between the two
groups 1 day after colonoscopy without sedation (Table 1).
After adjusting for age and sex, the pain score was
3.51  3.21 in Group A compared with Group B (pZ 0.055).
Table 2 shows the acceptance of the procedure and the
willingness to repeat the colonoscopy if necessary. No sig-
nificant difference was seen between the two groups in
acceptance for the procedure. The willingness to repeat
this procedure also had no significant difference between
the two groups [76/77 (98.7%) in Group A vs. 135/140
(96.4%) in Group B; Table 2].
Univariate analyses showed that female sex, meperidine
use, and endoscopist were associated with a higher risk of
severe abdominal pain (VAS 4) during colonoscopy without
sedation. After adjusting for other confounding factors,Table 1 Basic characteristics of study participants undergoing c
premedication.
With meperidine
(Group A; n Z 7
Male sex, % 40.3
Age (y) 51.6
Biopsy or polypectomy, n (%) 25 (32.5)
Abdominal pain
In process of examination 3.54  3.13
Male 2.81  3.04
Female 4.20  3.20
At end of examination 0.70  1.75
24 hours after examination 0.08  0.49
Cecal insertion time (min) 7.14  5.45
Withdrawal time (min) 6.82  5.00
Total cecum intubation rate (%) 100
Data are presented as mean  SD.
* p < 0.05.multivariate analyses showed that female sex had a
significantly higher risk of severe pain (VAS 4) during co-
lonoscopy (OR 2.313; 95% CI, 1.301e4.113; p Z 0.004).
Different endoscopists also correlated with severe pain
when compared with each other (Table 3).
Discussion
Our study showed that female sex and endoscopist were
associated with abdominal pain during colonoscopy without
sedation, but not an absence of premedication with
meperidine. Premedication with meperidine was not asso-
ciated with a difference in cecal intubation rate and total
insertion time during colonoscopy without sedation. Previ-
ous studies have shown that female sex, lower body mass
index, younger age, intubation time, bowel preparation
status, previous hysterectomy, use of antispasmodic drugs,
and the experience of the endoscopist were predictors of a
more painful experience for patients during colonoscopy
without sedation [13,14]. The subgroup and multivariate
analysis in our study confirmed that women experienced
more abdominal pain during colonoscopy without sedation
than men. All three endoscopists in this study had per-
formed more than 2000 colonoscopies each, but the pain
score still showed a significant inter-endoscopist differ-
ence. These results imply that even experienced endo-
scopists need continued training or an improvement of skills
in colonoscopy without sedation.
In this study, patients who received meperidine as a pre-
procedure analgesia experienced a greater severity of
abdominal pain. Although the proportion of women is
higher (59.7% vs. 40.3%) in the group using meperidine,
multivariate analysis did not show a significant correlation
between abdominal pain and meperidine. Contrary to
experience from usual practice and common belief, the
routine administration of meperidine prior to colonoscopy
does not reduce abdominal pain during this procedure.
These results suggest that colonoscopy without sedation is
well accepted and feasible whether premedication with
meperidine is used or not.olonoscopy without sedation with or without meperidine as a
7)
Without meperidine
(Group B; n Z 140)
p
55.7 0.034
50.7 0.410
60 (42.6) 0.134
2.46  2.75 0.009*
1.85  2.42 0.086
3.45  3.01 0.225
0.10  0.46 0.000*
0.14  0.78 0.495
6.24  4.24 0.309
7.69  5.33 0.330
99
Table 2 Acceptance of colonoscopy without sedation and willingness to undergo examination again.
With meperidine (Group A) Without meperidine (Group B) p
Acceptance, n (%)
Excellent 55 (71.4) 103 (73.9) 0.079
Good 18 (23.1) 29 (21.6)
Fair 4 (5.2) 1 (0.7)
Poor 0 (0) 1 (0.7)
NAa 0 (0) 6 (4.1)
Patient willing to undergo colonoscopy
without sedation again (%)
98.7 96.4 0.426
a In Group B, acceptance was not recorded in six patients. The remaining 134 patients were analyzed and compared with Group B.
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routine and may relieve patient anxiety and discomfort,
improve the outcome of the examination, and diminish the
patient’s memory of the event [15]. The most common
choice of sedative is benzodiazepine alone or in combina-
tion with an opiate. Meperidine is a common opioid drug
used for analgesia and partial sedation. Combinations of
benzodiazepine and opioid drugs are often used, but may
increase the risk of oxygen desaturation and cardiorespi-
ratory complications [15]. One previous study showed no
difference in abdominal pain during colonoscopy in patients
receiving a combination of midazolam and meperidine, or
either drug given alone [16]. However, another study
showed that a combination of these two drugs provided
better patient tolerance to the procedure and less pain
during the colonoscopy than midazolam alone [17].
In contrast with the USA, colonoscopy is commonly
performed without sedation in Taiwan and many Asian
countries. The advantages of colonoscopy without sedation
include the prevention of sedation-related complications,
reduction in recovery time after the procedure, and a lower
cost. A recent study also showed primary screening with
colonoscopy without sedation is feasible, as with sigmoid-
oscopy [13]. Meperidine is usually used for analgesia prior
to colonoscopy without sedation in our daily practice. It isTable 3 Association between risk factors and abdominal pain (v
analyses.
Risk factor Univariate analysi
Odds ratio 95%
int
Sex (female vs. male) 2.468 1
Age (>60 y vs. 60 y) 1.455 0
Meperidine (Group A vs. Group B) 1.916 1
Endoscopy procedure (biopsy/polypectomy
vs. no biopsy/polypectomy)
0.694 0
Previous abdominal surgery (with previous
abdominal surgery vs. without previous
abdominal surgery)
1.464 0
Endoscopista
A (M.C.T.) 2.018 0
B (T.H.C) 2.972 1
* p < 0.05.
a Endoscopist C.C.L. was used as reference.administered within 30 minutes prior to the examination via
the intramuscular route in our outpatient department;
however, some adverse effects such as dizziness, nausea,
vomiting, or hypotension may occur. In our findings, the
performance of the procedure and the patient’s abdominal
pain were not related to the use of meperidine during co-
lonoscopy without sedation. Meperidine may not be
necessary as a premedication for colonoscopy without
sedation.
Although sedation for colonoscopy is standard in the USA,
some facilities do offer the option of colonoscopy without
sedation. One recent study conducted in the USA noted that
28% of patients changed their choice from colonoscopy with
sedation to colonoscopy without sedation after being
informed of the advantages and disadvantages of these two
options. More than 90% of patients would accept further
colonoscopy with no sedation and 75% had a good or excel-
lent experience [7]. Our results also showed a high accep-
tance for colonoscopy without sedation (good or excellent in
more than 90% patients) and our patients were willing to
repeat the procedure without sedation. These studies sug-
gest that colonoscopy without sedation is well accepted in
the majority of patients. By promoting an informed choice
of colonoscopy without sedation and an explanation of the
advantages and disadvantages, we could reduce theisual analog scale 4 points) using univariate and multivariate
s Multivariate analysis
Confidence
erval
p Odds
ratio
95% CI p
.398e4.358 0.002 2.313 1.301e4.113 0.004*
.812e2.608 0.208
.081e3.396 0.026* 1.723 0.958e3.099 0.069
.391e1.232 0.212
.772e2.776 0.243
.942e4.323 0.071 1.861 0.857e4.041 0.116
.385e6.378 0.005 * 2.557 1.171e5.582 0.018*
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enormous cost and risk of cardiovascular complications.
In addition to abdominal pain, we evaluated several
quality indicators for colonoscopy (cecum reach rate,
insertion time, and withdrawal time) [18]. The three
endoscopists had good performances in colonoscopy
without sedation. Both groups had a high cecum reach rate
(more than 99%) and adequate insertion and withdrawal
times, as in other studies. The administration or non-
administration of meperidine did not influence the perfor-
mance of the colonoscopy without sedation.
Our study had several limitations. Firstly, it was not a
randomized study. The patients could choose to receive or
not receive meperidine prior to the colonoscopy and the
demographic data in this study showed a higher proportion
of women asking for meperidine. Secondly, the patients
who asked for analgesia may also have had underlying
anxiety or a fear of painful sensations. To overcome these
limitations, we need further randomized controlled trials
and to add to the questionnaire to evaluate the psychiatric
status of patients.
In conclusion, premedication with meperidine was not
associated with a reduction in abdominal pain during co-
lonoscopy without sedation. The insertion time and cecum
intubation rate showed no difference between patients
with or without meperidine. Premedication with meperi-
dine is not mandatory prior to colonoscopy without seda-
tion if the procedures are performed skillfully.Conflicts of interest
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